InstaDeep will use the funding to hire talent, improve its computing infrastructure and accelerate product launches, according to a Jan. 25 press release. Other investors are Chimera Abu Dhabi, Deutsche Bahn’s DB Digital Ventures, G42 and Synergie.
InstaDeep has previously collaborated with Google and BioNTech.
In 2020, BioNTech and InstaDeep formed a collaboration to use AI to develop new therapies, part of which included an early warning variant detection system for COVID-19, which has predicted more than 90 percent of variants around two months ahead of detection. It also has published joint research with Google’s DeepMind and Google Research.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
